What is the difference between Gonadorelin and Leuprolide?

Gonadorelin: Synthetic GnRH that binds pituitary GnRH receptors; pulsatile dosing stimulates LH/FSH release; used to maintain HPG axis during TRT Leuprolide: Continuous GnRH receptor stimulation causes receptor desensitization and downregulation. This suppresses LH/FSH → testosterone/estrogen to castrate levels.

Is Gonadorelin FDA approved?

Gonadorelin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is Leuprolide FDA approved?

Leuprolide is FDA approved (FDA status current as of 1985-04-08). This regulatory status is provided for research and educational context only.

How is Gonadorelin administered in research settings?

In research settings, Gonadorelin is typically administered via the subcutaneous or intravenous routes. PeptideBase does not provide dosing or administration instructions.

How is Leuprolide administered in research settings?

In research settings, Leuprolide is typically administered via the subcutaneous, intramuscular, or implant routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Gonadorelin vs Leuprolide

Peptide Comparison

Gonadorelin vs Leuprolide

Both are Reproductive & Hormonal peptides.

Gonadorelin

GnRH

Sexual HealthNot EvaluatedCompoundable

Half-life: ~2-4 minutes

25 providers listed

Full Gonadorelin profile →

Leuprolide

Lupron

Sexual HealthFDA ApprovedPrescription

2 providers listed

Full Leuprolide profile →

Bottom line

Leuprolide is FDA-approved, while Gonadorelin is not evaluated — the clearest structural difference between them.

Quick Verdict

Gonadorelin

Evidence

Established Clinical

Half-life

~2-4 minutes

Leuprolide

Evidence

Established Clinical

Half-life

—

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Leuprolide
Further along in FDA review	Leuprolide
More provider options (25 vs 2)	Gonadorelin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Gonadorelin

Leuprolide

Mechanism Family

Reproductive & Hormonal

Half-life

~2-4 minutes

—

FDA Status

not evaluated

approved

Admin Routes

subcutaneous, intravenous

subcutaneous, intramuscular, implant

Availability

Compoundable

Prescription

Providers

25 listed

2 listed

FDA Update

—

Apr 1985

Avail. Notes

Previously FDA-approved as Factrel (NDA 017019). Voluntarily discontinued by manufacturer. Included on the FDA 503B outsourcing-facility bulk-substances list (Category 1), not the 503A pharmacy list. Prescription compounded product.

FDA-approved: Lupron (leuprolide acetate), Drugs@FDA application 019010.

Research Evidence

Gonadorelin

Established ClinicalMeta-analysis · 5 key studies · most recent 2026

Leuprolide

Established ClinicalMeta-analysis · 19 key studies · most recent 2026

Research Citations

Gonadorelin

Cohort2026 · J Reprod Dev

Effect of post-insemination GnRH analogue administration on pregnancy rates in repeat-breeder cows: compariso…

Cohort2026 · J Dairy Sci

Increasing gonadorelin hydrochloride dose at the first GnRH of breeding Ovsynch enhances luteinizing hormone…

Cohort2025 · Translational Andrology and Urology

Therapeutic effects of a pulsatile GnRH pump on adult male patients with congenital hypogonadotropic hypogona…

Meta-analysis2018 · Fertility and Sterility

Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and fu…

+1 more

Leuprolide

Meta-analysis2024 · J Minim Invasive Gynecol

The Effect of Hormonal Treatment on Ovarian Endometriomas: A Systematic Review and Meta-Analysis

RCT1993 · Am J Obstet Gynecol

Depot leuprolide vs danazol for endometriosis: multicenter double-blind RCT

RCT1984 · New England Journal of Medicine

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

Cohort2026 · Int J Mol Sci

Terazosin as a Non-Hormonal Treatment for Endometriosis.

+15 more

About Gonadorelin

Synthetic GnRH that binds pituitary GnRH receptors; pulsatile dosing stimulates LH/FSH release; used to maintain HPG axis during TRT

Research Areas

pulsatile LH and FSH stimulation from the pituitarytesticular function and testosterone production maintenancefertility preservation alongside TRT (FSH pathway intact)hypothalamic-pituitary axis restoration in hypogonadism

About Leuprolide

Continuous GnRH receptor stimulation causes receptor desensitization and downregulation. This suppresses LH/FSH → testosterone/estrogen to castrate levels. Short-term pulsatile use can transiently stimulate the axis before suppression occurs.

Research Areas

HPG axis modulationtestosterone suppressionhormonal restartGnRH axis control

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Gonadorelin

Reported (Unverified — Pending Clinical Review)

continuous high-dose (causes receptor downregulation)

No established clinical contraindications

Suggested Monitoring

Total testosteroneLHFSHEstradiol (E2)SHBGProlactin

Standard reproductive endocrinology panels establish HPG axis baseline. LH and FSH confirm pituitary response to gonadorelin; testosterone, E2, and SHBG reflect downstream gonadal output.

Leuprolide

Absolute Contraindications

Under clinical review

Being verified by our medical team before we display contraindications for this peptide.

Suggested Monitoring

Under clinical review

Being verified by our medical team before we display monitoring guidance for this peptide.

Find Providers

Where to source these peptides

Providers offering

Gonadorelin

25 listed

Browse directory →

Providers offering

Leuprolide

2 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Reproductive & Hormonal Comparisons

Browse all peptides →

Educational research tools — not medical advice.